3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Interventions
enzalutamide
14
Docetaxel
7
radium Ra 223 dichloride
6
Abiraterone Acetate
6
Prednisone
5
darolutamide
4
abiraterone
3
olaparib
2
niraparib
2
atezolizumab
2
apalutamide
2
zimberelimab
1
xentuzumab
1
tasquinimod
1
sacituzumab govitecan
1
sabizabulin
1
quemliclustat
1
ipatasertib
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
cabazitaxel
1
Rosuvastatin Calcium
1
Radium-223
1
Pluvicto
1
Pioglitazone
1
Nivolumab
1
JNJ-64619178
1
JNJ-64264681
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Prostatic Neoplasms, Castration-Resistant
×
Radium-223
×
Clear all
NCT03563014
2020-05-20
BELFIGO
Bayer
Completed
164 enrolled